Apostolos E. Papalois | Medical Technology | Best Research Article Award

Published on by Network Awards

[ays_poll id=1]

Prof. Apostolos E. Papalois | Medical Technology | Best Research Article Award

Professor at Hellenic Society of Gastrointestinal Oncology, Athens | Greece

Prof. Apostolos E. Papalois is a distinguished biologist and academic leader with a PhD from the National and Kapodistrian University of Athens (NKUA). With a career spanning over three decades, he has made significant contributions in the fields of biomedical research, transplantation, bioethics, and medical education. He has served in various leadership roles internationally, including as Visiting Professor at Harvard Medical School, Chairman of the Special Unit for Biomedical Research and Education at Aristotle University of Thessaloniki (AUTH), and Secretary General of NASCE / UEMS Executive Board in Brussels. His work encompasses research, ethics, education, and translational medicine.

Professional Profile:

Education: 

Prof. Apostolos E. Papalois completed his PhD in Biology at the National and Kapodistrian University of Athens (NKUA), where his dissertation focused on pancreatic islet transplantation, liver cell transplantation, and artificial liver development, in collaboration with leading hospitals and the University of Cambridge (UK). His postgraduate training includes advanced studies at Harvard University, University of Minnesota, University of Cambridge, and University of Los Angeles, among others. He has also attended specialized seminars on Transplantation, Laboratory Animal Science, and Leadership at Harvard University.

Experience:

Prof. Apostolos E. Papalois has held numerous academic and administrative positions. He served as Director of the Research, Educational, and Experimental Center at ELPEN Pharmaceuticals for 25 years, where he led scientific and educational programs and established a scholarship initiative. He has taught at undergraduate and postgraduate levels at major universities in Greece and abroad and supervised numerous doctoral projects. He is currently Chairman of the Special Unit for Biomedical Research and Education at AUTH, Visiting Professor at Harvard Medical School, Academic Coordinator at the Open University of Cyprus, and Secretary General of NASCE / UEMS. Additionally, he is an active member of multiple scientific boards and committees, contributing to national policy-making in education, research, and innovation.

Research Interests:

Prof. Apostolos E. Papalois’s research interests include transplantation biology, regenerative medicine, pancreatic and liver therapies, experimental animal models, and clinical skills education. He has expertise in bioethics, medical ethics, and research governance, guiding both national and international efforts in advancing ethical medical practices. His translational work bridges laboratory research with clinical applications, particularly in improving treatment approaches for gastrointestinal diseases, cancer immunotherapy, and regenerative therapies.

Publications Top Noted:

  1. Fibrin glue and coats compromise the integrity of colonic anastomosis: an experimental trial on rats, Year: 2024, Citation: 3

  2. Immunotherapy of gastric cancer: Present status and future perspectives, Year: 2024, Citations: 13

  3. Mesenchymal Stem Cell Transplantation Has a Regenerative Effect in Ischemic Myocardium: An Experimental Rat Model Evaluated by SPECT-CT Assessment, Year: 2024, Citations: 2

  4. Combination treatment of inflammatory bowel disease: Present status and future perspectives, Year: 2024, Citations: 25

  5. Early-onset gastrointestinal cancer: An epidemiological reality with great significance and implications, Year: 2024, Citations: 6

Conclusion:

Prof. Apostolos E. Papalois embodies scientific excellence, visionary leadership, and ethical commitment in the medical research community. His groundbreaking work in transplantation biology and regenerative therapies continues to shape clinical practice and biomedical education worldwide. By fostering collaborations and mentoring emerging scientists, he has ensured the sustained growth and integrity of medical research. His contributions bridge the gap between laboratory discoveries and patient care, creating tangible benefits for healthcare systems globally. Recognition through the Best Research Article Award highlights his enduring influence and dedication to advancing medical technology for the betterment of society.

Rongbo Zhang | Medical Technology | Best Researcher Award

Published on by Network Awards

[ays_poll id=1]

Mr. Rongbo Zhang | Medical Technology | Best Researcher Award

Attending Physician at The Third Affiliated Hospital of Chongqing Medical University | China

Mr. Rongbo Zhang, M.Med., is an Attending Physician in the Department of Anesthesiology at the Third Affiliated Hospital of Chongqing Medical University. With expertise in multimodal analgesia, Enhanced Recovery After Surgery (ERAS) pathways, and non-intubated thoracic surgery (NIVATS), he has led innovative clinical research in perioperative pain management. His work on low-dose esketamine combined with paravertebral block has set new standards for opioid-sparing anesthesia, enhancing patient recovery and safety in thoracic surgery.

Professional Profile:

Education: 

Mr. Rongbo Zhang earned his Master of Medicine (M.Med.) in Anesthesiology from Chongqing Medical University, where he developed a strong foundation in clinical anesthesia, pain management, and surgical recovery protocols.

Experience:

Mr. Rongbo Zhang has served as an Attending Physician at the Third Affiliated Hospital of Chongqing Medical University. He designs and administers anesthesia protocols for more than 200 non-intubated video-assisted thoracic surgery (NIVATS) cases annually. His clinical leadership focuses on implementing paravertebral block (PVB) and opioid-sparing analgesic strategies, contributing to enhanced perioperative outcomes and reduced postoperative complications.

Research Interest:

  • Multimodal Analgesia – optimizing pain relief while minimizing opioid dependency.

  • Enhanced Recovery After Surgery (ERAS) Protocols – integrating anesthesia strategies into holistic patient recovery pathways.

  • Non-Intubated Thoracic Surgery (NIVATS) – advancing safer, less invasive anesthetic techniques.

  • Opioid-Sparing Anesthesia – clinical innovations reducing intraoperative and postoperative opioid use.

Publications Top Noted:

Title: The Effects of Low-Dose Esketamine Combined with Paravertebral Block on Postoperative Hyperalgesia and Enhanced Recovery in Non-Intubated Video-Assisted Thoracic Surgery: A Randomized Controlled Trial.

  • Year: 2025.

Conclusion:

Mr. Rongbo Zhang’s clinical leadership and innovative research in medical technology for anesthesia and perioperative care make him an exemplary candidate for the Best Researcher Award in Medical Technology. His pioneering work in opioid-sparing protocols and non-intubated thoracic surgery has transformed patient recovery standards in thoracic anesthesia. By expanding his global research presence, mentoring the next generation, and engaging in international collaborations, he is well-positioned to influence anesthesia practice worldwide. His achievements reflect the award’s mission of honoring researchers who drive innovative, safe, and patient-centered medical technologies.